Annual Total Assets
$282.62 M
-$46.30 M-14.08%
December 31, 2023
Summary
- As of February 7, 2025, ADAP annual total assets is $282.62 million, with the most recent change of -$46.30 million (-14.08%) on December 31, 2023.
- During the last 3 years, ADAP annual total assets has fallen by -$168.53 million (-37.36%).
- ADAP annual total assets is now -39.81% below its all-time high of $469.55 million, reached on December 31, 2021.
Performance
ADAP Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$317.44 M
-$4.27 M-1.33%
September 30, 2024
Summary
- As of February 7, 2025, ADAP quarterly total assets is $317.44 million, with the most recent change of -$4.27 million (-1.33%) on September 30, 2024.
- Over the past year, ADAP quarterly total assets has increased by +$59.43 million (+23.03%).
- ADAP quarterly total assets is now -38.03% below its all-time high of $512.20 million, reached on June 30, 2020.
Performance
ADAP Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
ADAP Total Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -14.1% | +23.0% |
| 3 y3 years | -37.4% | -10.2% |
| 5 y5 years | +2.1% | +52.4% |
ADAP Total Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -39.8% | at low | -32.4% | +23.0% |
| 5 y | 5-year | -39.8% | +55.7% | -38.0% | +74.8% |
| alltime | all time | -39.8% | >+9999.0% | -38.0% | +471.8% |
Adaptimmune Therapeutics Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $317.44 M(-1.3%) |
| Jun 2024 | - | $321.70 M(+24.7%) |
| Mar 2024 | - | $258.01 M(-8.7%) |
| Dec 2023 | $282.62 M(-14.1%) | $282.62 M(-4.7%) |
| Sep 2023 | - | $296.64 M(-13.5%) |
| Jun 2023 | - | $342.98 M(+19.1%) |
| Mar 2023 | - | $288.08 M(-12.4%) |
| Dec 2022 | $328.92 M(-30.0%) | $328.92 M(-1.0%) |
| Sep 2022 | - | $332.20 M(-14.4%) |
| Jun 2022 | - | $388.27 M(-7.5%) |
| Mar 2022 | - | $419.80 M(-10.6%) |
| Dec 2021 | $469.55 M(+4.1%) | $469.55 M(+32.8%) |
| Sep 2021 | - | $353.53 M(-9.3%) |
| Jun 2021 | - | $389.79 M(-5.3%) |
| Mar 2021 | - | $411.58 M(-8.8%) |
| Dec 2020 | $451.14 M(+148.5%) | $451.14 M(-5.8%) |
| Sep 2020 | - | $479.02 M(-6.5%) |
| Jun 2020 | - | $512.20 M(+79.6%) |
| Mar 2020 | - | $285.24 M(+57.1%) |
| Dec 2019 | $181.54 M | $181.54 M(-12.8%) |
| Sep 2019 | - | $208.25 M(-13.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $239.52 M(-11.4%) |
| Mar 2019 | - | $270.44 M(-2.3%) |
| Dec 2018 | $276.74 M(-1.6%) | $276.74 M(-10.6%) |
| Sep 2018 | - | $309.63 M(+46.5%) |
| Jun 2018 | - | $211.30 M(-14.5%) |
| Mar 2018 | - | $247.07 M(-12.1%) |
| Dec 2017 | $281.15 M(+19.9%) | $281.15 M(-6.7%) |
| Sep 2017 | - | $301.38 M(+6.0%) |
| Jun 2017 | - | $284.28 M(+6.9%) |
| Mar 2017 | - | $265.98 M(+13.4%) |
| Dec 2016 | $234.51 M(-18.0%) | $234.51 M(+5.3%) |
| Sep 2016 | - | $222.64 M(-7.1%) |
| Jun 2016 | - | $239.56 M(-8.4%) |
| Mar 2016 | - | $261.56 M(-12.0%) |
| Dec 2015 | $285.82 M(-4.9%) | - |
| Sep 2015 | - | $297.31 M(+115.9%) |
| Jun 2015 | $300.65 M(+441.5%) | - |
| Dec 2014 | - | $137.71 M(+148.1%) |
| Jun 2014 | $55.52 M(+2966.3%) | $55.52 M |
| Jun 2013 | $1.81 M(-54.3%) | - |
| Jun 2012 | $3.96 M | - |
FAQ
- What is Adaptimmune Therapeutics annual total assets?
- What is the all time high annual total assets for Adaptimmune Therapeutics?
- What is Adaptimmune Therapeutics annual total assets year-on-year change?
- What is Adaptimmune Therapeutics quarterly total assets?
- What is the all time high quarterly total assets for Adaptimmune Therapeutics?
- What is Adaptimmune Therapeutics quarterly total assets year-on-year change?
What is Adaptimmune Therapeutics annual total assets?
The current annual total assets of ADAP is $282.62 M
What is the all time high annual total assets for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high annual total assets is $469.55 M
What is Adaptimmune Therapeutics annual total assets year-on-year change?
Over the past year, ADAP annual total assets has changed by -$46.30 M (-14.08%)
What is Adaptimmune Therapeutics quarterly total assets?
The current quarterly total assets of ADAP is $317.44 M
What is the all time high quarterly total assets for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high quarterly total assets is $512.20 M
What is Adaptimmune Therapeutics quarterly total assets year-on-year change?
Over the past year, ADAP quarterly total assets has changed by +$59.43 M (+23.03%)